Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Bayer's new CT contrast injection system earns FDA clearance.

New contrast injection system inks FDA clearance

The system can be set up in as little as two minutes and needs just 20 seconds to prime in between patients. 

Thumbnail

Deep learning reconstruction cuts prostate MRI acquisition time

And the shorter scan time does not come at the expense of image quality.

AI model spots missed breast cancers on MRI

AI model spots up to 30% of breast cancers missed on MRI

Re-evaluation by the second look algorithm could result in a cancer diagnosis up to one year earlier, especially for high risk disease.

Thumbnail

The Mediterranean diet may slow brain aging, MRI study shows

Following the Mediterranean diet, especially one rich with plant-based foods, could have significant benefits for cognitive health. 

Researchers working to develop portable PET scanner

Researchers receive grant worth millions to develop portable PET scanner

Experts are hopeful that the portable scanner could improve access to neuroimaging used in the diagnosis and monitoring of Alzheimer's disease.

MRI accident prompts questions on safety

CMS to make proposed MRI safety codes official

The new code family was created to "capture the physician work involving patients with implanted medical devices that require access to MR diagnostic procedures."

‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

HeartLung Technologies, a Houston-based artificial intelligence (AI) company, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for new software that assesses chest CT scans for signs of coronary artery disease (CAD) and other potentially fatal heart conditions. The newly cleared offering, AutoChamber, was designed with opportunistic heart evaluations in mind.

FDA clears AI tool that flags signs of heart disease in chest CT scans

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.